Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
New research led by David Solomon, an assistant professor in the Department of Pathology at UCSF, provides much-needed targeted treatment options for patients whose tumors cannot be surgically removed.
USAID Awards Global Malaria Contract to UCSF's Malaria Elimination Initiative and Partners
The MEI is part of a group of partners that has been awarded a new contract by USAID to support the President’s Malaria Initiative’s Advancing the Progress of Malaria Service Delivery project in 28 countries.
For the sixth year, UCSF has placed among the top 20 colleges and universities that received the most charitable contributions in the nation. The distinction caps an extraordinary career for John B. Ford, who recently retired as vice chancellor of University Development and Alumni Relations.
Office visits offer doctors only a snapshot of chronic conditions. That’s where new mobile health-tracking technology can make a real difference, providing detailed and long-term health data for each patient.
Treatment with an investigational androgen receptor inhibitor significantly delayed the development of metastasis in patients with prostate cancer that had become resistant to standard androgen-deprivation therapy.
UCSF has received a $500 million commitment from the Helen Diller Foundation to support the planning, design and construction of a new, world-class hospital at the University’s historic Parnassus Heights campus, ensuring that UCSF can continue to provide premier care to patients in the San Francisco Bay Area and beyond in the 21st century.
A pilot program at UCSF was designed to deliver rapid-access medication management and psychotherapy services to patients with the goal of returning them to their primary care providers for continuing care once they have been stabilized.
An international team of researchers has shown that two different compounds, can safely and effectively be added to treatment regimens to block transmission of the most common form of malaria in Africa.